Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Amino Acid(19) and Alanyl Glutamine Injection versus 8.5% Compound Amino Acid(18AA-II) for postoperative total parenteral nutrition
ChiCTR-IPR-15005920Phase 3Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 1990
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of alanyl glutamine in deficiency disorders (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Glutamine and Prealbumin. Started Jan 1990; status: completed.
02
Drugs
alanyl glutamine
03
Conditions
deficiency disorders
Beyond the preview
Go deeper on ChiCTR-IPR-15005920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15005920.